Titanium Elastic Nailing Versus Hip Spica Cast in Treatment of Femoral Fractures in Children
NCT ID: NCT01190696
Last Updated: 2010-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
46 participants
INTERVENTIONAL
2009-02-28
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hip spica casting
Patients in the spica cast group treated with skeletal traction and spica cast applied for them
Hip spica casting
we applied cast for three weeks in patients with femoral shaft fracture
titanium elasting nailing
For patients in the Titanium Elasting Nailing group, the nail applied retrogradely in femoral shaft fracture
titanium elastic nailing
we inserted titanium nail in femoral fractures retrogradely
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
titanium elastic nailing
we inserted titanium nail in femoral fractures retrogradely
Hip spica casting
we applied cast for three weeks in patients with femoral shaft fracture
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isfahan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Isfahan University of Medical Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hamidreza shemshaki, MD
Role: STUDY_CHAIR
MD,research comittee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al-zahra university hospital
Isfahan, Isfahan, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASD-1213-5
Identifier Type: -
Identifier Source: org_study_id